日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Is CLL curable?

慢性淋巴细胞白血病可以治愈吗?

Jain, Nitin; Ferrajoli, Alessandra; O'Brien, Susan; Wierda, William

Clinical, genetic, and familial features of POT1 tumor predisposition syndrome

POT1肿瘤易感综合征的临床、遗传和家族特征

DiNardo, Courtney D; Croden, Jennifer; Abdel-Salam, Hiam M; Kadia, Tapan; Molica, Matteo; Bazinet, Alexandre; Bose, Prithviraj; Maiti, Abhishek; Haddad, Fadi; Burger, Jan; Kantarjian, Hagop; Wierda, William; Jain, Nitin; Ferrajoli, Alessandra

Automated natural language processing to identify venous thromboembolism from diagnostic imaging reports

利用自动化自然语言处理技术从诊断影像报告中识别静脉血栓栓塞

Subramanian, Naveen; Garcia Pleitez, Hector; Nguyen, Daniel; Milton, Denái R; Kebriaei, Partow; Shpall, Elizabeth; Cheng, Lee; Lu, Jing; Jin, Shida; Wu, Carol C; Sheth, Rahul A; Ferrajoli, Alessandra; Toale, Katy M; Kroll, Michael H; Rojas-Hernandez, Cristhiam M

Phase 1B pilot study of itacitinib with alemtuzumab in patients with T-cell prolymphocytic leukemia

伊他替尼联合阿仑单抗治疗T细胞前淋巴细胞白血病患者的1B期试点研究

Kadia, Tapan M; Jain, Akhil; Rausch, Caitlin R; Bataller, Alex; Ravandi, Farhad; Jabbour, Elias; Qiao, Wei; Borthakur, Gautam; Short, Nicholas; Montalban-Bravo, Guillermo; Quesada, Andres E; Burger, Jan; Ferrajoli, Alessandra; Wierda, William; Hosing, Chitra; Kantarjian, Hagop

Acalabrutinib-obinutuzumab improves survival vs chemoimmunotherapy in treatment-naive CLL in the 6-year follow-up of ELEVATE-TN

在ELEVATE-TN研究的6年随访结果中,阿卡替尼联合奥妥珠单抗治疗与化疗免疫疗法相比,可改善初治慢性淋巴细胞白血病患者的生存期。

Sharman, Jeff P; Egyed, Miklos; Jurczak, Wojciech; Skarbnik, Alan; Patel, Krish; Flinn, Ian W; Kamdar, Manali; Munir, Talha; Walewska, Renata; Hughes, Marie; Fogliatto, Laura Maria; Herishanu, Yair; Banerji, Versha; Follows, George; Walker, Patricia; Ghia, Paolo; Janssens, Ann; Byrd, John C; Ferrant, Emmanuelle; Ferrajoli, Alessandra; Wierda, William G; Wachira, Catherine Wangui; Suterwala, Batul T; Miranda, Paulo; Munugalavadla, Veerendra; Wun, Chuan-Chuan; Woyach, Jennifer A

Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia

维奈托克联合FLAG-IDA方案诱导和巩固治疗新诊断、复发或难治性急性髓系白血病的长期疗效

DiNardo, Courtney D; Jen, Wei-Ying; Takahashi, Koichi; Kadia, Tapan M; Loghavi, Sanam; Daver, Naval G; Xiao, Lianchun; Reville, Patrick K; Issa, Ghayas C; Short, Nicholas J; Sasaki, Koji; Wang, Sa A; Mullin, Jillian K; Pierce, Sherry; Bradley, Corey; Borthakur, Gautam; Maiti, Abhishek; Alvarado, Yesid; Pemmaraju, Naveen; Ferrajoli, Alessandra; Swaminathan, Mahesh; Ohanian, Maro; Abbas, Hussein A; Hammond, Danielle; Burger, Jan; Haddad, Fadi; Montalban-Bravo, Guillermo; Chien, Kelly; Masarova, Lucia; Yilmaz, Musa; Jain, Nitin; Andreeff, Michael; Garcia-Manero, Guillermo; Kornblau, Steven; Ravandi, Farhad; Jabbour, Elias; Konopleva, Marina Y; Kantarjian, Hagop M

Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progression

吡托布替尼治疗期间慢性淋巴细胞白血病患者的药理学特征及疾病进展

Tantawy, Shady I; Aslan, Burcu; Manyam, Ganiraju; Iles, LaKesla R; Timofeeva, Natalia; Singh, Neetu; Jain, Nitin; Ferrajoli, Alessandra; Thompson, Philip A; Patel, Keyur P; Desikan, Sai Prasad; Wierda, William G; Gandhi, Varsha

Hyper-CVAD and Sequential Blinatumomab Without and With Inotuzumab in Young Adults With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia

在初诊为费城染色体阴性B细胞急性淋巴细胞白血病的年轻成人患者中,采用Hyper-CVAD方案和序贯Blinatumomab方案(不联合或联合Inotuzumab)治疗。

Kantarjian, Hagop; Short, Nicholas J; Jain, Nitin; Haddad, Fadi G; Kadia, Tapan; Yilmaz, Musa; Ferrajoli, Alessandra; Sasaki, Koji; Alvarado, Yesid; Pemmaraju, Naveen; Senapati, Jayastu; Garris, Rebecca; Ravandi, Farhad; Jabbour, Elias

Cumulative review of hypertension in patients with chronic lymphocytic leukemia treated with acalabrutinib

对接受阿卡替尼治疗的慢性淋巴细胞白血病患者高血压的累积性回顾

Ferrajoli, Alessandra; Follows, George; Marmor, Yotvat; Roos, Jack; Bajwa, Naghmana; Madhira, Venkata; Nozaki, Kenji; Miranda, Paulo; Pennap, Dinci; Patel, Krish

Long-term follow-up of a phase 2 study of all-trans retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin in acute promyelocytic leukemia

全反式维甲酸、三氧化二砷和吉妥珠单抗奥佐米星治疗急性早幼粒细胞白血病的II期研究的长期随访

Jen, Wei-Ying; Marvin-Peek, Jennifer; Kantarjian, Hagop M; Alvarado, Yesid; Borthakur, Gautam; Jabbour, Elias; Wierda, William; Kadia, Tapan M; Daver, Naval G; DiNardo, Courtney D; Short, Nicholas J; Jain, Nitin; Ferrajoli, Alessandra; Kornblau, Steven; Yilmaz, Musa; Ohanian, Maro; McCue, David; Burger, Jan; Hammond, Danielle; Patel, Keyur; Issa, Ghayas C; Pemmaraju, Naveen; Sasaki, Koji; Maiti, Abhishek; Abbas, Hussein A; Chien, Kelly; Takahashi, Koichi; Haddad, Fadi; Bose, Prithviraj; Masarova, Lucia; Montalban-Bravo, Guillermo; Swaminathan, Mahesh; Brandt, Mark; Pierce, Sherry; Garcia-Manero, Guillermo; Ravandi, Farhad